Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
382
382 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- AZD7789Phase 21 trial
AstraZeneca · Carcinoma, Non-Small-Cell Lung, Gastric Cancer, Gastroesophageal Junction Cancer
- AZD8205Phase 21 trial
AstraZeneca · Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer
- BalstililmabPhase 21 trial
Nelum Corp · Untreated, Advanced Pancreatic Cancer
- BDC-4182Phase 21 trial
Bolt Biotherapeutics, Inc. · Gastric Cancer Adenocarcinoma Metastatic, Gastroesophageal Adenocarcinoma
- BHB810Phase 21 trial
BigHat Biosciences, Inc. · Gastric Cancer, Gastric Adenocarcinoma, Gastric (Stomach) Cancer
- BI 3802876Phase 21 trial
Boehringer Ingelheim · Liver Cirrhosis
- BI 770371Phase 21 trial
Boehringer Ingelheim · Compensated Liver Cirrhosis, Metabolic Dysfunction Associated Steatohepatitis (MASH)
- BLU-924SAR449336Phase 21 trial
Blueprint Medicines Corporation · Advanced Solid Tumor, Non-Small Cell Lung Cancer, Colorectal Neoplasms
- BMS-986523Phase 21 trial
Bristol Myers Squibb · Advanced Solid Malignancies, Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
- BPI-572270Phase 21 trial
Betta Pharmaceuticals Co., Ltd. · Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC)
- CBX-12Phase 21 trial
Cybrexa Therapeutics · Solid Tumor, Adult, Epithelial Ovarian Cancer, Small Cell Lung Carcinoma
- certepetideCEND-1, LSTA1Phase 21 trial
Lisata Therapeutics, Inc. · Cholangiocarcinoma, Gallbladder Cancer, Gallbladder Carcinoma
- CGT4859Phase 21 trial
Cogent Biosciences, Inc. · Intrahepatic Cholangiocarcinoma (Icc), Cholangiocarcinoma, Other Solid Tumors, Adult
- CNP-104Phase 21 trial
COUR Pharmaceutical Development Company, Inc. · Primary Biliary Cholangitis
- CP-383Phase 21 trial
Tasca Therapeutics · Solid Tumor Malignancies, Colorectal Carcinoma, Small Cell Lung Cancer ( SCLC )
- CPT-11Phase 21 trial
Zhejiang Doer Biologics Co., Ltd. · Gastrointestinal Cancer
- CR-002Phase 21 trial
Crescent Biopharma, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Gastric/GEJ, Biliary Tract Cancer (BTC)
- CSG452Phase 21 trial
Kowa Research Institute, Inc. · NASH
- CT041Phase 21 trial
CARsgen Therapeutics Co., Ltd. · Gastric Cancer, Pancreatic Cancer
- CT3001Phase 21 trial
Crossignal Therapeutics, Inc. · Solid Tumor, Adult, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma
- DB-1324Phase 21 trial
DualityBio Inc. · Gastrointestinal Cancer
- DCC-3009Phase 21 trial
Deciphera Pharmaceuticals, LLC · Gastrointestinal Stromal Tumor (GIST)
- DD01Phase 21 trial
Neuraly, Inc. · NAFLD, NASH
- Decoy20Phase 21 trial
Indaptus Therapeutics, Inc · Solid Tumor, Adult, HCC - Hepatocellular Carcinoma, CRC (Colorectal Cancer)
- DM002Phase 21 trial
Xadcera Biopharmaceutical (Suzhou) Co., Ltd. · Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms
- DONQ52Phase 21 trial
Chugai Pharmaceutical · Celiac Disease
- DR30206Phase 21 trial
Zhejiang Doer Biologics Co., Ltd. · Gastrointestinal Cancer
- E7090Phase 21 trial
Eisai · Cholangiocarcinoma
- E7386Phase 21 trial
Eisai · Endometrial Neoplasms, Neoplasms, Carcinoma, Hepatocellular
- ECC0509Phase 21 trial
Eccogene · Metabolic Dysfunction-associated Steatohepatitis
- EF-009Phase 21 trial
Everfront Biotech Co., Ltd. · Pancreatic Cancer
- EfineptakinNT-I7, rhIL-7-hyFcPhase 21 trial
NeoImmuneTech · Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer
- efocipegtrutideHM15211Phase 21 trial
Hanmi Pharmaceutical Company Limited · NASH - Nonalcoholic Steatohepatitis
- EGEN-5784Genetically Engineered Porcine Liver, xenogeneic porcine liverPhase 21 trial
eGenesis, INC · Acute on Chronic Liver Failure (ACLF), Hepatic Encephalopathy (HE)
- EIK1005Phase 21 trial
Eikon Therapeutics · Advanced Solid Tumors, MSI-H or dMMR Advanced Solid Tumors, MSI-H/dMMR Gastric Cancer
- EP-104GIPhase 21 trial
Eupraxia Pharmaceuticals Inc. · Eosinophilic Esophagitis
- ERAS-0015Phase 21 trial
Tango Therapeutics, Inc. · PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC
- ETX-929Phase 21 trial
Ensem Therapeutics · Metastatic Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Non-squamous, Non-Small Cell Lung Cancer
- F573Phase 21 trial
Beijing Continent Pharmaceutical Co, Ltd. · Acute Liver Failure, Acute-On-Chronic Liver Failure
- FB102Phase 21 trial
Forte Biosciences, Inc. · Celiac Disease
- gavo-celPhase 21 trial
TCR2 Therapeutics · Mesothelioma, Mesothelioma, Malignant, Mesothelioma; Pleura
- GEN1042Phase 21 trial
Genmab · Malignant Solid Tumor, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
- GFS202APhase 21 trial
Genfleet Therapeutics (Shanghai) Inc. · Pancreatic Cancer
- GI-108Phase 21 trial
GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Non-small Cell Lung Cancer (NSCLC)
- GNS561Phase 21 trial
Genfit · Cholangiocarcinoma
- GTAEXS617REC-617Phase 21 trial
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Pancreatic Adenocarcinoma, Non-small Cell Lung Cancer (NSCLC)
- HCW9218Phase 21 trial
ImmunityBio, Inc. · Advanced Pancreatic Carcinoma
- HK-660SPhase 21 trial
CuromeBiosciences · Primary Sclerosing Cholangitis (PSC)
- HMBD-001Phase 21 trial
Hummingbird Bioscience · Advanced or Metastatic Squamous Non-Small Cell Lung Cancer, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Esophageal Squamous Cell Carcinoma
- HP515Phase 21 trial
Hinova Pharmaceuticals Inc. · NAFLD (Non-alcoholic Fatty Liver Disease)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.